(Q51089625)

29 March 2018

title

Factor structure of social fears: The Liebowitz Social Anxiety Scale. (English)

1 reference

29 March 2018

author name string

Safren SA

1

1 reference

29 March 2018

Heimberg RG

2

1 reference

29 March 2018

Horner KJ

3

1 reference

29 March 2018

Juster HR

4

1 reference

29 March 2018

Schneier FR

5

1 reference

29 March 2018

Liebowitz MR

6

1 reference

29 March 2018

publication date

1 May 1999

1 reference

29 March 2018

Journal of Anxiety Disorders

published in

1 reference

29 March 2018

volume

13

1 reference

29 March 2018

page(s)

253-270

1 reference

29 March 2018

issue

3

1 reference

29 March 2018

Reliability of DSM-III-R Anxiety Disorder Categories

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Factor analysis in the development and refinement of clinical assessment instruments

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Psychometric properties of the Liebowitz Social Anxiety Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Assessment of anxiety in social interaction and being observed by others: The social interaction anxiety scale and the Social Phobia Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Validity of the distinction between generalized social phobia and avoidant personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Social anxiousness: the construct and its measurement.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Homework compliance, perceptions of control, and outcome of cognitive-behavioral treatment of social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

1 reference

7 January 2021

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Reliability of anxiety assessment. I. Diagnostic agreement.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Generalized social phobia. Reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Brief standard self-rating for phobic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Development and validation of measures of social phobia scrutiny fear and social interaction anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Moclobemide in social phobia: a controlled dose-response trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

A pilot study of treatment of social phobia with alprazolam.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Factor structure of the Social Interaction Anxiety Scale and the Social Phobia Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Placebo-controlled trial of moclobemide in social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Pharmacotherapy of Social Phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Avoidant personality disorder and the generalized subtype of social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Clients' expectancies and their relationship to pretreatment symptomatology and outcome of cognitive-behavioral group treatment for social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2899%2900003-1

7 January 2021

10.1016/S0887-6185(99)00003-1

Identifiers

DOI

1 reference

29 March 2018

PubMed ID

10372341

1 reference

29 March 2018